 |
|
Higher folate levels linked to reduced risk for Alzheimer's disease
January 09, 2007Individuals who take in higher levels of the nutrient folate through both diet and supplements may have a reduced risk of developing Alzheimer's disease, according to a report in the January issue of Archives of Neurology, one of the JAMA/Archives journals.
By the year 2047, the prevalence of Alzheimer's disease is expected to quadruple, according to background information in the article. Delaying the onset of this neurodegenerative disease would significantly reduce the burden it causes. Researchers suspect that elevated levels of the amino acid homocysteine in the blood, which is linked to a higher risk for cardiovascular disease and stroke, may also increase the risk for Alzheimer's disease. Folate, vitamin B12 and vitamin B6, are important in the body's processing of homocysteine-therefore, deficiencies in these nutrients increase homocysteine levels and may contribute to cardiovascular disease, stroke and dementia.
José A. Luchsinger, M.D., Columbia University Medical Center, New York, and colleagues examined, interviewed and assessed the diets of 965 individuals without dementia between 1992 and 1994 and then followed them for an average of 6.1 years to see if they developed Alzheimer's disease. The participants had an average age of 75.8 and 70.2 percent were women, 32.6 percent African-American, 45.3 percent Hispanic and 22.1 percent white.
During the follow-up period, 192 of the participants developed Alzheimer's disease. When the individuals were divided into four groups based on the total level of folate they took in through food and supplements and the analysis was adjusted for patient characteristics, comorbid diseases and B12 and B6 intake, the risk of Alzheimer's disease was lower in the groups with higher intake. Neither dietary folate nor supplements alone were significantly linked to Alzheimer's disease risk; only the two in combination appeared to produce an effect. Levels of the vitamins B12 and B6 were not associated with Alzheimer's disease risk.
Higher folate intake was modestly correlated with lower homocysteine levels, "indirectly suggesting that a lower homocysteine level is a potential mechanism for the association between higher folate intake and a lower Alzheimer's disease risk," the authors write.
Definitive conclusions about the role of folate in the development of Alzheimer's disease cannot yet be made, they continue. The findings of this study are in contrast to those of some other research, and other compounds (such as hormones) perceived to reduce the risk for dementia in observational studies did not do so in randomized trials. "Thus, the decision to increase folate intake to prevent Alzheimer's disease should await clinical trials," they conclude.
JAMA and Archives Journals
During the follow-up period, 192 of the participants developed Alzheimer's disease. When the individuals were divided into four groups based on the total level of folate they took in through food and supplements and the analysis was adjusted for patient characteristics, comorbid diseases and B12 and B6 intake, the risk of Alzheimer's disease was lower in the groups with higher intake. Neither dietary folate nor supplements alone were significantly linked to Alzheimer's disease risk; only the two in combination appeared to produce an effect. Levels of the vitamins B12 and B6 were not associated with Alzheimer's disease risk.
Higher folate intake was modestly correlated with lower homocysteine levels, "indirectly suggesting that a lower homocysteine level is a potential mechanism for the association between higher folate intake and a lower Alzheimer's disease risk," the authors write.
Definitive conclusions about the role of folate in the development of Alzheimer's disease cannot yet be made, they continue. The findings of this study are in contrast to those of some other research, and other compounds (such as hormones) perceived to reduce the risk for dementia in observational studies did not do so in randomized trials. "Thus, the decision to increase folate intake to prevent Alzheimer's disease should await clinical trials," they conclude.
JAMA and Archives Journals
Alzheimer Current Events and Alzheimer News RSSUniversity of the Basque Country study on proteins related to Alzheimer
The cause, or at least one of the possible causes, of memory loss amongst Alzheimer sufferers is related to the location of certain proteins.
Ben-Gurion University Alzheimer's researcher demonstrates specific immune response to vaccine
A researcher who is working on a vaccine for Alzheimer's disease (AD) has demonstrated that it is possible to test and measure specific immune responses in mice carrying human genes and to anticipate the immune response in Alzheimer's patients.
August 10, 2009 New Class of Compounds Discovered for Potential Alzheimer's Disease Drug, Penn Study Finds
A new class of molecules capable of blocking the formation of specific protein clumps that are believed to contribute to the dementia of Alzheimer's disease (AD) patients has been discovered by researchers at the University of Pennsylvania School of Medicine.
Study by NTU professors provides important insight into apoptosis or programmed cell death
A study by Nanyang Technological University (NTU)'s Assistant Professor Li Hoi Yeung, Assistant Professor Koh Cheng Gee and their team have made an important contribution to the understanding of the process that cells go through when they die.
A research work carried out in mice will contribute to the study of hereditary diseases that lead to blindness
Noticias UGR Researchers of the University of Granada (Spain) have used a technique consisting of the induction of neuronal degeneration neuronal for intense light exposure in the mouse's retina that will be helpful for the study of retinitis pigmentosa (RP), a group of hereditary diseases which lead to blindness and affect more than one million persons a year all over the world.
Delirium in hospitalized adults: Situation critical, no relief available
Every year as many as seven million adults in the United States experience delirium during hospitalization.
Neural stem cell differentiation factor discovered
Neural stem cells represent the cellular backup of our brain. These cells are capable of self-renewal to form new stem cells or differentiate into neurons, astrocytes or oligodendrocytes.
New data demonstrate potential for early detection of Alzheimer's disease
Data published in the June issue of the Journal of Alzheimer's Disease demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress (OS) levels in blood plasma, which may prove to be a useful biomarker in the early detection of Alzheimer's disease.
Another McGill/JGH breakthrough opens door to early Alzheimer's diagnosis
A new diagnostic technique which may greatly simplify the detection of Alzheimer's disease has been discovered by researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital (JGH).
Measuring brain atrophy in patients with mild cognitive impairment
Scientists at the University of California, San Diego School of Medicine have shown that a fully automated procedure called Volumetric MRI - which measures the "memory centers" of the brain and compares them to expected size - is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease.
More Alzheimer Current Events and Alzheimer News Articles
 |
Alzheimer's from the Inside Out by Richard Taylor (Author) Receiving a diagnosis of Alzheimer’s disease profoundly alters lives and creates endless uncertainty about the future. How does a person cope with such a life-changing discovery? What are the hopes and fears of someone living with this disease? How does he want to be treated? How does he feel as the disease alters his brain, his relationships, and ultimately himself?
Richard Taylor provides illuminating responses to these and many other questions in this collection of provocative essays. Diagnosed with Alzheimer’s disease at age 61, the former psychologist courageously shares an account of his slow transformation and deterioration and the growing division between his world and the world of others.
With poignant clarity, candor, and even occasional humor, more than... |
 |
A Caregiver's Guide to Alzheimer's Disease: 300 Tips for Making Life Easier by Patricia R. Callone (Editor) Written for patients, their families, and caregivers, the practical information here will help readers understand what is physically happening to the brain so they can empower their own special skills and talents throughout the disease process. The book is divided into three sections that correspond to the progression of Alzheimer’s, and the unique challenges encountered at each stage. *Section A: The four stages of Alzheimer's with hundreds of practical tips for coping at each level *Section B: Q&A for caregivers, including legal and financial issues, medication, helping children understand, handling the holidays and more. *Section C: Resources and websites. This is an essential book for all those who want to focus on the capabilities that... |
 |
Learning to Speak Alzheimer's: A Groundbreaking Approach for Everyone Dealing with the Disease by Joanne Koenig Coste (Author), Robert Butler (Foreword) More than four million Americans suffer from Alzheimer’s, and as many as twenty million have close relatives or friends with the disease. Revolutionizing the way we perceive and live with Alzheimer’s, Joanne Koenig Coste offers a practical approach to the emotional well-being of both patients and caregivers that emphasizes relating to patients in their own reality. Her accessible and comprehensive method, which she calls habilitation, works to enhance communication between carepartners and patients and has proven successful with thousands of people living with dementia. Learning to Speak Alzheimer’s also offers hundreds of practical tips, including how to · cope with the diagnosis and adjust to the disease’s progression · help the patient talk about the illness · face the... |
 |
The Alzheimer's Project Starring: Maria Shriver Alzheimer’s is the second-most-feared illness in America following cancer, and it is the nation’s sixth leading cause of death. Is such anxiety justified? The answer, until recently, was not comforting. The Alzheimer’s Project consists of 4 films. The anchor of The Alzheimer’s Project series is Momentum in Science which features 25 leading scientists, a primetime state-of-the-science report revealing the most cutting-edge research advances. The three additional primetime specials (The Memory Lost Tapes; Grandpa, Will You Remember Me? With Maria Shriver; and Caregivers) capture what it means to experience the disease, to be a child or grandchild of one who suffers, and to care for those who are affected. Alzheimer’s is an irreversible and progressive brain disease that slowly... |
 |
The 36-Hour Day, 4th edition: A Family Guide to Caring for People with Alzheimer Disease, Other Dementias, and Memory Loss in Later Life (A Johns Hopkins Press Health Book) by Nancy L. Mace MA (Author), Peter V. Rabins MD MPH (Author) Revised in 2006 for its twenty-fifth anniversary, this best-selling book is the "bible" for families caring for people with Alzheimer disease, offering comfort and support to millions worldwide. In addition to the practical and compassionate guidance that have made The 36-Hour Day invaluable to caregivers, the fourth edition is the only edition currently available that includes new information on medical research and the delivery of care. The new edition includes: -new information on diagnostic evaluation-resources for families and adult children who care for people with dementia-updated legal and financial information-the latest information on nursing homes and other communal living arrangements-new information on research, medications, and the biological causes and... |
 |
The 36-Hour Day: A Family Guide to Caring for Persons with Alzheimer Disease, Related Dementing Illnesses, and Memory Loss in Later Life (3rd Edition) by Nancy L. Mace (Author), Peter V. Rabins (Author) This classic family guide to caring for persons with Alzheimer's disease, related dementia, and memory loss in later life is now available in this user-friendly, oversized mass market edition. Reissue. |
 |
Inside Alzheimer's: How to Hear and Honor Connections with a Person who has Dementia by Nancy Pearce (Author) We have long underestimated the person who has dementia. Each one's ability to reach out in familiar ways certainly diminishes yet he or she is always able to experience the deep benefits that come from being in vital relationship with others. Inside Alzheimer's tells how dozens of persons with dementia and their sharing of wisdom, humor and life's teachings led Ms. Pearce to the six basic principles of connection--how one person connects with another: Intend a connection, Free yourself of judgment, Love, Open to receive love, Silence and Thankfulness. Internalizing these principles has empowered hundreds of family, friends, and professionals to create moments of connection with persons, regardless of how advanced the dementia. |
 |
Alzheimer's Early Stages: First Steps for Family, Friends and Caregivers by Daniel Kuhn (Author), M.D. David A. Bennett (Foreword) This edition includes the latest information on Alzheimer’s risk factors, treatments, and prevention, as well as a new chapter, "Voices of Experience," composed of reflections by family members. It also provides information about new drugs approved since 1999 and the federal government’s decision to cover counseling and other health-related services through Medicare. |
 |
Prevagen Aequorin, 30-Count Bottle by Prevagen PrevagenTM is a ground breaking dietary supplement from a jellyfish and is designed to fight aging. Scientific studies show a decrease in cellular death by up to 50 percent when treated with Prevagen. Prevagen is the first supplement to address aging through the restoration of calcium-binding proteins. Replenish age-fighting proteins, feel younger, and have more energy with Prevagen. You lose it, Prevagen Replaces it Throughout the aging process your body loses its ability to make calcium-binding proteins.* The lack of these protective proteins can result in the death of your cells that are involved in learning and memory. Prevagen is designed to replace these proteins and help you fight aging.* The animation to the left demonstrates how Prevagen can replenish... |
 |
Still Alice by Lisa Genova (Author) Still Alice is a compelling debut novel about a 50-year-old woman's sudden descent into early onset Alzheimer's disease, written by first-time author Lisa Genova, who holds a Ph. D in neuroscience from Harvard University. Alice Howland, happily married with three grown children and a house on the Cape, is a celebrated Harvard professor at the height of her career when she notices a forgetfulness creeping into her life. As confusion starts to cloud her thinking and her memory begins to fail her, she receives a devastating diagnosis: early onset Alzheimer's disease. Fiercely independent, Alice struggles to maintain her lifestyle and live in the moment, even as her sense of self is being stripped away. In turns heartbreaking, inspiring and terrifying, Still Alice captures in remarkable... |
| © 2009 BrightSurf.com |